OLIVIERI, JACOPO
 Distribuzione geografica
Continente #
NA - Nord America 723
EU - Europa 467
AS - Asia 85
OC - Oceania 2
Totale 1.277
Nazione #
US - Stati Uniti d'America 722
IT - Italia 131
UA - Ucraina 76
FR - Francia 55
SE - Svezia 53
IE - Irlanda 46
DE - Germania 31
TR - Turchia 28
DK - Danimarca 27
GB - Regno Unito 19
CN - Cina 18
FI - Finlandia 16
SG - Singapore 16
KR - Corea 13
IN - India 6
BE - Belgio 4
PL - Polonia 4
AU - Australia 2
CH - Svizzera 2
NL - Olanda 2
TH - Thailandia 2
CA - Canada 1
IR - Iran 1
RU - Federazione Russa 1
VN - Vietnam 1
Totale 1.277
Città #
Chandler 132
Jacksonville 81
Ashburn 53
Fairfield 48
Dublin 46
Centro 39
New York 39
Wilmington 34
Seattle 27
Woodbridge 26
Houston 24
Boardman 22
Ann Arbor 20
Cambridge 20
Lawrence 18
Princeton 18
Beijing 16
San Mateo 16
Des Moines 14
Redmond 14
Turin 12
San Diego 10
Cagliari 6
Porto 6
Leawood 5
Marche 5
Pune 5
Ancona 4
Bologna 4
Bristol 4
Los Angeles 4
Rome 4
Washington 4
London 3
Milan 3
Bangkok 2
Brussels 2
Cremona 2
Helsinki 2
Malo 2
Palermo 2
Parma 2
Prescot 2
Sydney 2
Zurich 2
Bubbiano 1
Bushey 1
Cedar Knolls 1
Chiaravalle 1
Chicago 1
Chiswick 1
Dong Ket 1
Fayetteville 1
Florence 1
Guangzhou 1
Hanover 1
Hounslow 1
Inzago 1
Izmir 1
Kilburn 1
Macerata 1
Modena 1
Montecassiano 1
Montesilvano 1
Nanjing 1
New Bedfont 1
New Delhi 1
Ottawa 1
Paris 1
Redwood City 1
Sabz 1
Udine 1
Totale 833
Nome #
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi 101
A novel method to evaluate prethawing viability of cryopreserved CD34+ hematopoietic stem cells for autologous transplantation. 96
Predicting failure of hematopoietic stem cell mobilization before it starts: The predicted poor mobilizer (pPM) score 93
The Exaggerated Collagen Expression in Gvhd-Fibroblasts Is Effectively Inhibited By Therapeutic Concentration of Nilotinib 81
Reversal of poor graft function with iron-chelating therapy after allogeneic transplantation for severe aplastic anemia 80
Long lasting biological effects of PDGFR agonistic auto-antibodies in scleroderma 79
In vitro comparison of different TKI activity in T-Cell populations: selective sparing of Treg by Nilotinib. 78
Tailored Therapy in an Unselected Population of 91 Elderly Patients with DLBCL Prospectively Evaluated Using a Simplified CGA. 75
A Combination of Lenalidomide and Rituximab (ReRi) As Salvage Therapy in Elderly Patients Affected By Diffuse Large B Cells (DLBCL) Lymphoma Relapsed and Refractory 75
A new method to assess the viability of collected CD34+ cells before reinfusion: a prospective study in 50 autotransplanted patients. 72
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD 71
Modern management of anthracycline-induced cardiotoxicity in lymphoma patients: Low occurrence of cardiotoxicity with comprehensive assessment and tailored substitution by nonpegylated liposomal doxorubicin 70
Meccanismi del danno cellulare da chemioterapici su cellule normali e neoplastiche 70
Preventive Effects of Cardotoxicities By Liposomal Anthracyclines non Pegilated in 95 Perspective Patients Affected By Lymphoma and Monitored By Biomarkers and Ecocardiography 67
Tirosin kinase inhibitors in chronic graft versus host disease: from bench to bedside. 65
Consensus recommendations for improvement of unmet clinical needs-the example of chronic graft-versus-host disease: A systematic review and meta-analysis 64
Nilotinib Treatment of Patients Affected by Chronic Graft-versus-Host Disease Reduces Collagen Production and Skin Fibrosis by Downmodulating the TGF-β and p-SMAD Pathway 36
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO) 31
Nilotinib in steroid-refractory cGVHD: prospective parallel evaluation of response, according to NIH criteria and exploratory response criteria (GITMO criteria) 17
Totale 1.321
Categoria #
all - tutte 6.360
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.360


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20198 0 0 0 0 0 0 0 0 0 0 3 5
2019/2020170 16 2 14 0 32 1 19 12 23 4 10 37
2020/2021276 21 31 39 3 29 5 24 22 29 22 27 24
2021/2022157 6 29 1 2 1 9 16 8 8 20 26 31
2022/2023353 28 51 20 25 27 50 1 26 72 2 42 9
2023/2024185 30 3 14 28 23 61 4 14 2 6 0 0
Totale 1.321